The University of Utah spinout is using deep learning technology to power image analysis in pathology.

Techcyte, a US-based healthcare technology spinout of University of Utah, closed a $4.3m series A round yesterday that included undisclosed strategic partners and unnamed employees.

A range of existing shareholders also participated in the round. Techcyte has not named investors in its $1.7m seed round, raised in 2016.

Founded in 2013, Techcyte has developed a digital pathology platform that uses deep learning technology to analyse and store medical images. The platform has applications in research, human and veterinary diagnostics, air…